{
  "id": "e1806e1f93d5a3f0",
  "title": "STAT+: A seasoned biotech VC looks to 2026 and sees a wave of IPOs coming",
  "description": "One of the biotech industry\u2019s most esteemed venture capitalists anticipates that, after two years of drought, a wave of drug companies are set to go public.",
  "content": "One of the biotech industry\u2019s most esteemed venture capitalists anticipates that, after two years of drought, a wave of drug companies are set to go public.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2025/12/22/biotech-public-companies-ipos/?utm_campaign=rss",
  "published_at": "2025-12-22T09:30:00+00:00",
  "fetched_at": "2025-12-23T00:22:44.609575+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "venture capital",
    "ipo",
    "drought",
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: A seasoned biotech VC looks to 2026 and sees a wave of IPOs coming",
    "description": "One of the biotech industry\u2019s most esteemed venture capitalists anticipates that, after two years of drought, a wave of drug companies are set to go public.",
    "url": "https://www.statnews.com/2025/12/22/biotech-public-companies-ipos/?utm_campaign=rss",
    "published": "2025-12-22T09:30:00+00:00",
    "source": "STAT"
  }
}